PharmaCompass

wins backing for Crohn's indication
News Flash:- Pharmaceutical
to the European Medicines Agency (EMA) are backing approval of Janssen\'s Stelara, bringing the drug closer to becoming the first interleukin (IL)-12/23 inhibitor licensed for Crohn\'s disease.
http://ow.ly/GNWw304psvE www.pharmacompass.com

caught in legal tussle over 'patent infringement'
News Flash:- Ltd
decided to take legal action after Lupin filed an abbreviated new drug application (Anda) for a generic version of Pennsaid
www.pharmacompass.com http://ow.ly/wsQM304pqwz

partners Takeda for chikungunya vaccine
News Flash:- PHARMS USA; Takeda GmbH
firm ZydusBSE -0.84 % Cadila today announced partnership with \'s Takeda Pharmaceutical Company Ltd to develop vaccine for .
www.pharmacompass.com http://ow.ly/kren304pqbz

surges on heavy volumes
News Flash:- Limited
.S. Pfizer Inc\'s breast cancer drug, Ibrance, should be given marketing approval, an advisory committee at the European Medicines Agency recommended.
www.pharmacompass.com http://ow.ly/VcaU304kzlE